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Abstract
Escherichia coli is a highlydiverse groupofpathogens ranging fromcommensal of the intestinal tract, through to intestinal pathogen,
andextraintestinalpathogen.Here,wepresentdataonthepopulationdiversityofE. coli, usingBayesiananalysis to identify13distinct
clusters within the population from multilocus sequence typing data, which map onto a whole-genome-derived phylogeny based on
62 genome sequences. Bayesian analysis of recombination within the core genome identified reduction in detectable core genome
recombination as one moves from the commensals, through the intestinal pathogens down to the multidrug-resistant extraintestinal
pathogenic clone E. coli ST131. Our data show that the emergence of a multidrug-resistant, extraintestinal pathogenic lineage of
E. coli is marked by substantial reduction in detectable core genome recombination, resulting in a lineage which is phylogenetically
distinct and sexually isolated in terms of core genome recombination.
Key words: E. coli, recombination, population, diversity.
Introduction
Escherichia coli is a bacterial species of enormous diversity,
ranging from a harmless intestinal commensal organism of a
myriad of animals, through environmental organism, to zoo-
notic intestinal pathogen, and causative agent of extraintesti-
nal infections such as urinary tract infection (UTI) and
bacteremia (Croxen and Finlay 2010). Classical attempts at
classifying E. coli have centered on simplistic methods such
as pathotype where strains have been classified as commen-
sals, EHEC, EPEC, ETEC, EIEC, EAEC, or ExPEC based on the
disease pathology they are most associated with (Kaper et al.
2004). Phylogenetically E. coli can be separated into phy-
logroups based on a small number of discrete genetic markers
(Clermont et al. 2000), which show a degree of correlation
with isolation from host or niche. More advanced genotyping
techniques such as multilocus sequence typing (MLST [Wirth
et al. 2006]) have highlighted the shortcomings of pathotype
distinction with sequence types (STs) of E. coli often spanning
pathotypes (Olesen et al. 2012). The higher discriminatory
power of MLST also identified more phylogroups within
E. coli, the borders of which are clouded due to recombination
(Wirth et al. 2006).
Indeed, recombination has played a central role in the well-
described diversity observed within E. coli. The majority of re-
combination studies have focused on the vast level of hori-
zontal gene transfer and genetic acquisition across E. coli,
which is often intrinsic to the pathogenic lifestyle of the or-
ganism (Dobrindt et al. 2004). Such are the levels of horizontal
exchange of mobile genetic elements across E. coli that the
accessory genome of the organism is essentially open (Rasko
et al. 2008). Neither is the genetic exchange of accessory
elements limited within subgroups of E. coli such as ST or
phylogroup with toxigenic phage, pathogenicity islands, and
antimicrobial resistance plasmids transcending across all sub-
group boundaries as exemplified by the mosaic genomics of
the E. coli O104 outbreak strain (Rasko et al. 2011). This re-
combination-derived mosaicism has presented a problem in
untangling the population structure of E. coli and the evolu-
tionary relationship between the various pathogenic variants.
Furthermore, because most studies of recombination in E. coli
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have focused on the transfer of accessory elements between
pathotypes, very little is known on how recombination in the
core genome of E. coli varies across the population or how
that variation is related to pathogenesis or niche. Creating a
better understanding of core genome recombination has re-
cently been shown to provide evolutionary insights into the
important human pathogens Enterococcus faecium, Strepto-
coccus pneumonia, and Neisseria spp. (Hanage et al. 2009;
Corander et al. 2012; Willems et al. 2012), and it has been
shown that differences in levels of recombination across a
population are closely linked with ecological factors. Studies
based on the diversity of E. coli using MLST suggest that re-
combination has played a key role in the evolution of virulence
and the emergence of strains with increased pathogenesis
(Wirth et al. 2006), whereas studies based on a limited
number of genome sequences have suggested that both ho-
mologous and nonhomologous recombination have played a
role in evolution of pathogenesis, though there is sexual iso-
lation between phylogroups A/B1, B2, and E (Didelot et al.
2012).
In this study, we utilize algorithms designed for estimating
recombination and population structure in large genome data
sets, namely BratNextGen (Marttinen et al. 2012) and
Bayesian population genetics software (BAPS) (Corander
et al. 2008) to analyze the population structure of E. coli
and determine how recombination correlates with pathogen-
esis. We analyzed the entire E. coli MLST data set (mlst.ucc.ie)
and genome data for 62 E. coli strains representing the se-
quenced diversity of the organism. The genomes used range
from commensal K12 laboratory strains, to intestinal patho-
genic strains, through to strains associated with extraintestinal
infections such as UTI, and culminating in a number of strains
of E. coli ST131. ST131 has emerged over the last decade to
become the globally dominant strain type associated with ex-
traintestinal disease and dissemination of multidrug resistance,
leading to it being termed the pandemic E. coli (Rogers et al.
2011). By utilizing the most comprehensive set of data and
analytical tools to date, we provide new insights into recom-
bination and population structure in E. coli. Whole-genome
phylogeny shows concordance with traditional phylogroups,
with advanced Bayesian population analysis of the MLST data
set for E. coli suggesting the presence of 13 separated popu-
lation clusters, which exhibit admixture throughout. Detailed
analysis of core genome recombination suggests an evolution-
ary pattern from ubiquitous intestinal commensal exhibiting
relatively frequent core genome recombination, through to
highly specialized extraintestinal pathogen marked by a drastic
decrease in detectable core genome recombination, and in
the case of the newly emerged multidrug-resistant ST131,
an almost stable core genome that is sexually isolated from
the rest of the species including the most closely related
phylogroup B2 ExPEC strains. These findings further our un-
derstanding of the processes involved in evolution of patho-
genesis within the enterobacteriaceae, illustrating how core
genome recombination levels correlate to environmental
niche and pathogenesis in E. coli and provide new avenues
of research in understanding the emergence of global
pathogens.
Materials and Methods
Genome Data
A total of 62 publically available E. coli genome sequences
were used in this analysis (table 1). Fifty are reference genome
sequences available from NCBI, whereas 12 are ST131 ge-
nomes produced during previous studies in our group (Clark
et al. 2012).
MLST Data
In an attempt to provide a higher level of resolution to the pop-
ulation, we performed BAPS analysis using the data available
on the entire E. coli MLST database as of September 2012
(supplementary table S1, Supplementary Material online). The
database contained (accessed 1 September 2012) 2,880 STs
for which public and nonaberrant allele sequences were
available.
Whole-Genome-Based Phylogeny
Genome sequences were aligned using Mugsy (Sahl et al.
2011) and the core genome extracted using Mothur
(Schloss et al. 2009) with the default settings of the methods.
The resulting alignment was used to determine a maximum
likelihood (ML) phylogeny using RAxML (Stamatakis et al.
2005) implementing the rapid bootstrap function and the
general time reversible (GTR) model with Gamma correction,
with 100 bootstraps performed. The best tree was imported
into Figtree (http://tree.bio.ed.ac.uk/software/figtree/, last
accessed March 31, 2013) for graphical annotation.
Bayesian Population Genetics Software
BAPS (Tang et al. 2009) was applied to cluster the MLST data
into genetically distinct groups and to estimate the level of
admixture for each ST. The analyses were performed with
the second-order Markov model and the standard MLST
data input option, similarly as described in Hanage et al.
(2009). The optimal clustering was obtained using 10 runs
of the estimation algorithm with the prior upper bound of
the number of clusters varying in the range (Corander et al.
2012) over the 10 replicates. Each of the estimation runs did
yield a highly congruent partition of the ST data compared
with the other runs, such that there were exactly 13 clusters,
indicating a highly peaked posterior distribution in the neigh-
borhood of these partitions (estimated posterior probability
1.000). The admixture analysis was subsequently performed
using the 13 clusters in the estimated posterior mode partition
with 100 Monte Carlo replicates for allele frequencies and by
generating 100 reference genotypes to calculate P values. For
reference cases, we used 10 iterations in estimation according
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to the guidelines of Corander and Marttinen (2006). STs were
concluded to be significantly admixed when the P value did
not exceed the threshold of 5%.
MLST-Based Phylogeny
The phylogenetic distribution of the BAPS clusters was deter-
mined using an ML tree estimated with FastTree (Price et al.
2009) using the default settings (1,000 bootstrap replicates
with the general time-reversible model and Gamma model for
rate heterogeneity) based on the concatenated MLST data
over the seven loci for all identified MLST STs.
BratNextGen
Software package BratNextGen (Marttinen et al. 2012) was
used to determine recombining regions in the whole-genome
data comprising the 62 sequences. The estimation was per-
formed with the default settings as in Marttinen et al. (2012)
using 10 iterations of the estimation algorithm, which was
assessed to be sufficient because changes in the hidden
Markov model parameters were already negligible over the
last couple of iterations. Significance of a recombining region
was determined as in Marttinen et al. (2012) using a permu-
tation test with 100 permutations executed in parallel on a
cluster computer (threshold of 5% was used to conclude sig-
nificance for each region).
Statistical Testing of Significance in Differences of
Recombination Levels
To investigate whether the observed differences in the
amount of recombination are accountable by random varia-
tion within and between lineages, we performed standard
permutation tests. For a given labeling of strains into two
groups, we calculated first the absolute value of the difference
in the mean estimated amount of recombination between the
two groups. This resulted in the observed statistic T_obs. Then,
under the null hypothesis of no systematic difference in re-
combination between the groups, the group labels were ran-
domly permuted among strains and the corresponding value
of the statistic T_perm was calculated. To obtain a P value for
T_obs under the null hypothesis, the permutation procedure
was repeated 1,000,000 times, which yields an estimate of
the probability P(T_perm> T_obs).
Phylogeny of Recombining Regions and Core Genomes
with Recombining Regions Removed
FastTree was used with the same settings as for the MLST to
determine the phylogeny of significantly recombining regions
and core genomes with significantly recombining regions re-
moved. For each group of strains defined by the MLST BAPS
clustering, the fractions of recombinations shared within and
between groups were determined from the BratNextGen
output. In addition, the r/m ratio was estimated for each
Table 1
List of Escherichia coli Genome Data Used in This Study
Strain ST BAPS
Cluster
Pathotype Accession
Number
E. coli CE10 62 8 K1 ExPEC NC_017646
E. coli DH1 –ECDH1 1,060 5 K12 CP001637.1
E. coli ME8659 1,060 5 K12 AP012030.1
E. coli DH10B 1,060 5 K12 NC_010473.1
E. coli W3110 10 5 K12 AC000091
E. coli MG1655 10 5 K12 U00096.2
E. coli BW2952 10 5 K12 CP001396.1
E. coli P12b 10 5 K12 NC_017663.1
E. coli H10407 48 5 ETEC FN649414
E. coli UMNK88 100 5 K88 CP002729.1
E. coli REL606 93 5 B CP000819.1
E. coli BL21 DE3 93 5 B CP001509.3
E. coli ATCC9637 1,079 3 W CP002185.1
E. coli SE11 156 3 Human commensal AP009240.1
E. coli E23477A 1,132 3 ETEC CP000800.1
E. coli IAI1 1,128 3 O:8 CU928160.2
E. coli 55989 678 1 EAEC CU928145.2
E. coli C227_11 678 1 O104 AFRH00000000
E. coli 12009 17 1 O103 EHEC AP010958.1
E. coli 11128 16 3 O111 EHEC AP010960.1
E. coli 11368 21 3 O26 EHEC AP010953.1
E. coli ATCC8739 1,120 5 K12 CP000946.1
E. coli HS 46 7 Human commensal CP000802.1
E. coli CB9615 335 9 O55 EHEC CP001846.1
E. coli EDL933 11 9 O157 EHEC AE005174.2
E. coli Sakai 11 9 O157 EHEC BA000007.2
E. coli TW14359 11 9 O157 EHEC CP001368.1
E. coli EC4115 11 9 O157 EHEC NC_011353.1
E. coli XuZhou21 11 9 O157 EHEC NC_017906.1
E. coli RM12579 335 9 O55 EHEC NC_017656.1
E. coli O42 414 6 EAEC FN554766.1
E. coli UMNO26 597 6 O:7 ExPEC CU928163.2
E. coli SMS35 354 8 Multidrug resistant CP000970.1
E. coli E2348/69 15 4 O127 EPEC FM180568.1
E. coli UTI18 131a 4 ExPEC ERP001095
E. coli EC958 131b 4 ExPEC CAFL01000001
E. coli NA114 131c 4 ExPEC CP002797.1
E. coli P2U 131d 4 ExPEC ERX159100
E. coli P5U 131d 4 ExPEC ERX159106
E. coli P2B 131d 4 ExPEC ERX159099
E. coli UTI24 131a 4 ExPEC ERP001095
E. coli UTI32 131a 4 ExPEC ERP001095
E. coli UTI62 131a 4 ExPEC ERP001095
E. coli UTI188 131a 4 ExPEC ERP001095
E. coli UTI226 131a 4 ExPEC ERP001095
E. coli UTI306 131a 4 ExPEC ERP001095
E. coli UTI423 131a 4 ExPEC ERP001095
E. coli UTI587 131a 4 ExPEC ERP001095
E. coli SE15 131a 4 Human commensal AP009378.1
E. coli LF82 135 4 AIEC NC_011993.1
E. coli IHE3034 95 4 ST95 ExPEC CP001969.1
E. coli UTI89 95 4 ST95 ExPEC CP000243.1
E. coli S88 95 4 O45 ExPEC CU928161.2
E. coli APEC01 95 4 APEC CP000468.1
E. coli UM146 643 4 AIEC CP002167.1
E. coli 536 127 4 O6 ExPEC CP000247.1
E. coli LF82 135 4 AIEC CU651637.1
E. coli NRG857c 135 4 AIEC CP001855.1
E. coli ED1a 452 4 O81 CU928162.2
ABU83972 73 4 Asymptomatic CP001671
E. coli CFT073 73 4 ExPEC AE014075.1
E. coli Di14 73 4 ExPEC CP002212.1
E. coli Di12 73 4 ExPEC CP002211.1
a2009 UK ST131 isolates.
b2004 UK ST131 Isolate.
cIndian ST131 isolate.
d2012 UK ST131 isolates.
Recombination in Drug Resistant ExPEC GBE
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group from the number of single-nucleotide polymorphisms
(SNPs) residing within and outside of the recombinant
segments.
Results
Whole-Genome Phylogeny of E. coli and Determination
of Population Structure from MLST Data
To determine the phylogeny of the 62 E. coli strains in our
analysis (table 1), a whole-genome alignment was performed
using Mugsy and the core genome extracted to infer phylog-
eny using RaxML. The core genome is composed of
2,336,639 bp and shows concordance with previous E. coli
whole-genome phylogenies (Rasko et al. 2011) with hierarchi-
cal clustering based around Phylogroup (fig. 1). The E. coli
ST131 strains also show very tight clustering in concordance
with previous findings (Clark et al. 2012), though additionally
this phylogeny places strains from the United Kingdom and
India isolated between 2004 and 2010 (Avasthi et al. 2011;
Totsika et al. 2011; Clark et al. 2012) in a monophyletic clade
exhibiting very low diversity, furthering the suggestion that
ST131 may be a globally disseminated clone. However,
there is also the formation of a second cluster of E. coli
ST131 strains comprising the reference genome strain SE15
and two additional strains isolated in the United Kingdom in
2012 none of which exhibit antimicrobial resistance.
In an attempt to provide a higher level of resolution to the
population, we performed BAPS analysis using the data avail-
able on the entire E. coli MLST database (mlst.ucc.ie) as of 1
September 2012 (supplementary table S1, Supplementary
Material online), which resulted in the identification of 13
BAPS clusters. The database contained 2,880 STs for which
public and nonaberrant allele sequences were available. The
phylogenetic distribution of the clusters was determined using
an approximate ML tree estimated with FastTree (fig. 2). This
shows that recombination has blurred the boundaries of line-
ages to a considerable degree but not uniformly over all the
lineages. Notably, apart from a small subset of STs within
BAPS cluster 4, this cluster forms a monophyletic clade.
Mapping of BAPS clusters onto the whole-genome phylogeny
(fig. 1 and supplementary fig. S1, Supplementary Material
online) identified BAPS cluster 4 isolates as all belonging to
phylogroup B2 and all being ExPEC strains with the exception
of E234869, which is the reference O127 EPEC strain. All K12
strains are contained within BAPS cluster 5, except HS that
belongs to BAPS cluster 7, and all O55 and O157 EHEC strains
are within BAPS cluster 9. The phylogroup B1 clade contains
two discrete BAPS clusters within it. The majority are within
BAPS cluster 3 except the two EAEC strains 55989 and
C227_11 (E. coli O104) and strain 12009 (O103 EHEC),
which are in BAPS cluster 1. This population grouping con-
firms that pathotypes are not a robust way to differentiate
E. coli and that phylogroups can also be distributed across the
population. Our data provide a population framework to
MLST supporting 13 distinct populations and in particular a
clearly distinct BAPS cluster 4 containing only phylogroup B2
extraintestinal pathogenic STs. Determination of the levels of
admixture across the BAPS clusters based on MLST data
(fig. 3) supports the idea of discrete clusters but with signifi-
cant recombination. A summary of the admixture results is
given in supplementary table S2, Supplementary Material
online. Notably, BAPS MLST cluster 4 is the sole cluster harbor-
ing STs from a single ancestral group only, B2 (supplementary
table S4, Supplementary Material online). For a majority of the
BAPS clusters, several ancestral groups are found within a
single cluster. Among all clusters with at least 50 STs assigned
to allow for more robust estimation of subpopulation charac-
teristics, the frequency of admixed STs is smallest in cluster 4,
and furthermore, the mean fraction of DNA atypical for the
cluster is also smallest.
Quantification of Recombination with BratNextGen
Shows Varied Recombination Frequencies across BAPS
Clusters
To further examine the level of recombination across the BAPS
clusters, we interrogated our data set comprising 62 aligned
whole genomes using BratNextGen (fig. 4). The results clearly
show an uneven level of recombination across the BAPS clus-
ters with the E. coli ST131 clade within BAPS cluster 4 display-
ing very little recombination with an average value of just
0.39% of the core genome undergoing recombination.
There is then an increase in recombination moving into the
remaining BAPS cluster 4 ExPEC isolates and BAPS cluster 9
EHEC strains, and onward into the BAPS cluster 1, 3, 6, 7, and
8 strains associated with intestinal disease, culminating in the
BAPS cluster 5 K12 strains exhibiting the highest level of re-
combination at an average 2.19% of the core genome.
Quantitative analysis of differences between the recombina-
tion levels of the BAPS clusters was performed using permu-
tation tests (fig. 5), which showed that the resistant ST131
strains within BAPS cluster 4 had significantly less recombina-
tion than the other strains with multiple isolates present ST73,
ST95, and ST135 (P¼ 0.000001) and that the K12 strains of
BAPS cluster 5 (ST10, ST1060) exhibited significantly higher
levels of core genome recombination than strains in ST73,
ST95, and ST135 (P¼0.00001). This is indicative of a sliding
scale of core genome recombination, starting with high levels
in the commensal K12 strains, reducing into the intestinal
pathogenic strains, further still into the highly virulent intesti-
nal pathogenic EHEC and the extraintestinal pathogenic
strains, culminating in the pandemic, multidrug-resistant
ST131 extraintestinal pathogenic strains. To ensure that
these differences in core genome recombination cannot be
explained away by reduced level of genome diversity within
any particular MLST lineage included in the comparisons, we
calculated from the nonrecombinant genome segments
McNally et al. GBE
702 Genome Biol. Evol. 5(4):699–710. doi:10.1093/gbe/evt038 Advance Access publication March 14, 2013
 at N
ational Library of H
ealth Sciences on A
ugust 10, 2016
http://gbe.oxfordjournals.org/
D
ow
nloaded from
 
relative SNP distances between all pairs of isolates within each
lineage (ST73, ST95, ST135, and resistant ST131). Two-sample
Kolmogorov–Smirnov (K-S) test was used to examine whether
the distribution of SNP distances was markedly different be-
tween any pair of these lineages. Notably, mean relative SNP
distance between two isolates was highest within the resistant
ST131 among these four MLST lineages, thus indicating that
the identified reduction in core genome recombination
cannot be plausibly explained by the lineage being “younger”
and less diverse than the other lineages. K-S test yielded a
nonsignificant result when the distributions of relative SNP
distances were compared between resistant ST131 and
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FIG. 1.—Whole-genome-based phylogeny of Escherichia coli. The phylogeny is based on approximately 2.3-Mbp core genome aligned using Mugsy,
with an ML phylogeny determined using RAxML. Classical phylogroup is indicated at each clade of the tree with the appropriate capital letter. Strains are
further color coded according to allocated BAPS cluster (yellow¼BAPS 4, ST131 isolates with black border; brown¼BAPS 7; purple¼BAPS 5; light
blue¼ BAPS 3; red¼ BAPS 1; dark blue¼ BAPS 9; cyan¼BAPS 6; green¼ BAPS 8). The calculated r/m value for each major clade is also presented.
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Cluster 6
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Cluster 7
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Cluster 4
Cluster 8
FIG. 3.—Graphical representation of genetic admixture between the Escherichia coli BAPS population clusters as determined by BAPS analysis of MLST
data. The colors on the fringes of each cluster denote introgression of DNA from that source cluster into the recipient cluster.
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FIG. 2.—ML phylogeny of the Escherichia coli population based on concatenated MLST data. Each taxa in the tree is a different ST present in the E. coli
MLST database and is color coded by its allocated BAPS cluster.
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ST73, ST95 (P¼1.000), whereas significant difference was
observed between ST135 and the other lineages (P¼ 0.0001).
Our BratNextGen analysis also appears to suggest that the
recombining regions in each BAPS cluster are largely specific
to that particular cluster and that there is a degree of sexual
isolation between the clusters. This has been suggested before
with respect to phylogroups A+ B1, B2, and E (Didelot et al.
2012), but our analysis indicates this could be occurring at a
level beyond phylogroups. To determine whether core
genome recombination is sexually limited across BAPS clusters,
we extracted the recombining regions from our core genome
data set and inferred phylogeny from them using FastTree
(fig. 6). The resulting phylogeny mirrors that of the entire
core genome supporting the suggestion that there is no sig-
nificant recombination between BAPS clusters at the core
genome level. To confirm the phylogeny, we calculated the
proportion of recombinant segments in each BAPS cluster
(including a separate calculation for ST131), which were in-
tracluster specific, and the proportion of recombinant seg-
ments, which were shared across clusters, or intercluster
recombination events. The resulting data clearly support the
theory of recombination being favored to occur between
strains from the same cluster within BAPS cluster 4 and 9,
with ST131 showing a large bias toward intra-ST131 recom-
bination. Together our data provide extra insights into the
sexual isolation of the ST131 group, which phylogenetically
is very tightly clustered and at a further distance from all other
strains than at a whole-genome level.
We examined the areas of the core genome in which re-
combination was detected in each BAPS cluster by mapping
the regions onto an annotated pseudomolecule of the core
E. coli genome, highlighting the presence of the majority of
recombination events in CDS, though with some intergenic
regions also recombining. There was no physical clustering of
recombination in distinct regions of the chromosome, which
may be suggestive of hotspots or multiple insertions via a
single recombination event in any of the 62 strains.
Similarly, there was no association with recombination in
any functional category of gene in any BAPS cluster nor was
there any association with a particular gene in any cluster,
which might infer some obvious biological relevance regard-
ing niche or pathogenesis. This is in contrast to a recent article
suggesting recombination hotspots in the rfb operon, ﬁmA,
and the aroC locus (Didelot et al. 2012); however, we make no
comment on the validity of these findings. Indeed, further
analysis of all the recombinant regions across all 62 genomes
is currently the focus of a significant body of work, in the hope
it may add to our hypothesis on the role of ecology in defining
the recombination patterns described here.
Discussion
Escherichia coli is a highly diverse organism, which ranges
from the intestinal commensal K12 strains, through to intes-
tinal pathogenic variants such as ETEC, EAEC, and EPEC, to
severe intestinal pathogens such as E. coli O157, and then
extraintestinal pathogenic variants causing UTIs and bac-
teremia. This enormous diversity has made E. coli the subject
of countless comparative and evolutionary studies attempting
to determine the mechanisms by which each of the subgroups
has diversified and specialized (Dykhuizen and Green 1991;
Touchon et al. 2009). The recent emergence of the multidrug-
resistant E. coli O:25b:H4 ST131 as the globally dominant
strain type isolated from extraintestinal infections (Peirano
and Pitout 2010) provides a new and important dimension
to the study of how E. coli evolves and diversifies. ST131
strains first came to prominence in the early 21st century as
the strain type responsible for drug-resistant outbreaks of
community acquired bacteremia (Lau et al. 2008; Nicolas-
Chanoine et al. 2008; Ender et al. 2009; Pitout et al. 2009;
Rooney et al. 2009) since when it has become the dominant
strain type associated with UTIs (Johnson et al. 2010; Croxall
et al. 2011; Platell et al. 2011; Zong and Yu 2011). Genome
sequence data are suggestive of global dissemination of a
highly successful clone of ST131 (Clark et al. 2012), unlike
other recently emerged globally successful E. coli such as
0.39%
1.27%
1.95%
1.23%
0.79%
2.19%
0.86%
1.07%
1.13%
0.5Mb 1Mb 1.5Mb 2Mb
FIG. 4.—Graphical representation of recombination across 62 Escher-
ichia coli genome sequences as determined by BRATNextGen analysis.
Colored bars on the left indicate the BAPS cluster to which each strains
in the analysis belongs to (yellow¼ BAPS 4; brown¼BAPS 7;
purple¼ BAPS 5; light blue¼ BAPS 3; red¼ BAPS 1; dark blue¼ BAPS
9; cyan¼ BAPS 6; green¼ BAPS 8). Each strain in the analysis is a dash
on the y axis of the diagram. The x axis is marked by base pair position
relative to the core genome pseudomolecule formed from the whole-
genome alignment. Bars in the diagram represent regions of recombina-
tion detected within the core genome of each strain, with the color coding
of the bars allocated in an arbitrary manner. The figure to the left of BAPS
color indicator denotes the average percentage of recombination in the
core genome for that lineage.
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E. coli O157, which is a diverse population of organisms (Bono
et al. 2012). Also unlike O157, the dominant emergence of
ST131 does not seem to be linked to any increased virulence
phenotype (Johnson et al. 2012) or any set of specific or
unique genetic loci (Clark et al. 2012) other than dissemina-
tion of CTX-M 15.
Our reconstruction of the whole-genome-informed phy-
logeny of E. coli is in good agreement with previously pub-
lished phylogenies (Rasko et al. 2008, 2011; Lukjancenko et al.
2010; Didelot et al. 2012) but is the first to contain all the
ST131 genomes sequenced to date (Avasthi et al. 2011;
Totsika et al. 2011; Clark et al. 2012), as well as three new
genome sequences isolated in the United Kingdom in 2012
(P5U, P2U, and P2B) and the strain SE15 that is published as an
O150 strain isolated as a human commensal (Toh et al. 2010)
but which STs as an ST131 using the MLST scheme. The phy-
logenetic tree shows ST131 are clustered within the phy-
logroup B2 ExPEC strains as expected and form two distinct
groups, the first containing SE15 and two of the new UK 2012
isolates. The second contains all the O:25b and multidrug-re-
sistant isolates spanning an 8-year period and from the United
Kingdom and India and shows very little diversity, in concor-
dance with earlier data from our group (Clark et al. 2012).
Phylogeny alone provides very little detail as to how distinct
lineages of E. coli arose or indeed what distinct lineages are
beyond the classical phylogrouping. Our BAPS analysis based
on all publicly available MLST data suggests the presence of 13
distinct population clusters within the E. coli population. These
clusters are remarkably well in agreement with the lineages
detected in the core genome phylogeny (fig. 1), and when the
concatenated MLST phylogeny and resulting BAPS groupings
for the whole-genome sequence strains is compared with the
whole-genome phylogeny, there is direct concordance (sup-
plementary fig. S1, Supplementary Material online). The major
exception to this agreement is found within the phylogroup
B1 where the genome-wide information intermixes strains
from the BAPS clusters 1 and 3, possibly due to that fact
that both these clusters are human intestinal pathogens,
which also colonize the intestinal tracts of livestock, therefore
sharing ecological niche. ST131 is found in BAPS cluster 4,
which contains all the phylogroup B2 ExPEC strains in our
phylogeny and also displays the lowest levels of admixture
across all the E. coli populations. All other classical phy-
logroups are disseminated across multiple BAPS clusters. This
would suggest BAPS cluster 4 is a population of more “clonal”
strains of E. coli that are linked by their association with
FIG. 5.—Graph showing the percentage of core genome undergoing recombination in each of the 62 genomes in our analysis. Bars are color coded
according to the BAPS cluster that strain is allocated to (yellow¼ BAPS 4, light yellow ST131 strains within BAPS 4; brown¼ BAPS 7; purple¼BAPS 5; light
blue¼ BAPS 3; red¼ BAPS 1; dark blue¼ BAPS 9; cyan¼ BAPS 6; green¼ BAPS 8). Bars with values above the ST131 and K12 strains indicate P values for
significant difference between that group of strains and all others as determined by standard permutation tests.
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extraintestinal infection and that is marked by a reduction in
admixture events from outwith the subpopulation. To confirm
this further, we conducted a fuller investigation of recombi-
nation at the whole-genome level using BRATNextGen. The
whole-genome recombination analysis clearly shows the
ST131 strains within BAPS cluster 4 having a marked decrease
in the level of detectable core genome recombination when
compared with the other E. coli in our analysis, though the
levels in the non-ST131 BAPS cluster 4 strains are similar to
those observed in the intestinal pathogens with the exception
of BAPS cluster 9 containing E. coli O157 and its direct ances-
tral relative E. coli O55 (Leopold et al. 2009), which display the
next lowest levels of detectable core recombination after
ST131. The highest levels of core genome recombination
are found in K12 strains located in BAPS cluster 5, which is
perhaps unsurprising given many of these are derivatized lab-
oratory strains and intestinal commensals. The finding of
reduction in recombination associated with increased patho-
genesis in E. coli is in direct contrast to the findings of Wirth
et al. (2006), which utilized MLST data and population genetic
analysis on the data set to infer that increased virulence in
E. coli was a result of increased recombination. The discrep-
ancy between our study and theirs may be due to level of
resolution afforded by the analysis of dozens of complete
and draft genome sequences, as well as the Bayesian analysis
programs utilized in our study, providing a detailed analysis of
recombination across entire core genomes rather than a very
small subset of selected genes as in MLST. This argument is
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strengthened by the fact that our data presented here are in
agreement with that of Didelot et al. (2012) in that recombi-
nation patterns indicate a trend toward sexual isolation in
phylogroup B2.
Our finding of reduction in recombination of the core
genome in the globally disseminated, multidrug-resistant
ST131 clone is in direct agreement with recent findings in
other pathogens. The most striking analogy is with hospital-
associated strains of Ent. faecium displaying increased
virulence and antimicrobial drug resistance, which have
arisen through limited recombination events, followed by a
marked decrease in detectable core genome recombination
leading to clonal expansion of a successful variant (Willems
et al. 2012). The successful spread of such a clonal lineage
could be due to a selective advantage for strains, which avoid
the loss of advantageous phenotypes via recombination.
Another observation from our data is how the recombination
that is detected is primarily limited to within BAPS clusters in
E. coli, which is seen most clearly when a phylogeny is derived
from the recombining regions alone, mirroring the core
genome phylogeny, and the levels of intracluster recombina-
tion are determined. This would support a similar pattern of
recombination in evolution of E. coli as that described in the
hospital-associated Ent. faecium, with recombination being
restricted as a pathogenic clone becomes successful and
more niche adapted. As such in E. coli, we observe high
levels of recombination in the intestinal commensal K12, re-
ducing through the intestinal pathogens, and then restriction
and sexual isolation as the dominant ST131 clone emerges as
an extraintestinal pathogen with high levels of multidrug re-
sistance. Of course such restriction is limited to the core
genome as it is well known that accessory genome elements
such as plasmids and phage easily transfer across our deter-
mined BAPS clusters as is seen with the CTXM-15 plasmid and
the shiga-toxin-like phage crossing into the E. coli O104 strain
(Rasko et al. 2011). However, transfer of pathogenicity islands
may actually also be restricted if one considers that the islands
associated with uropathogenicity are only found in phy-
logroup B2 E. coli (Lloyd et al. 2007, 2009). Given that
ST131 is a classical phylogroup B2 strain containing classical
ExPEC-specific virulence factors and that the main difference
between ST131 and its near BAPS cluster 4 neighbors is ex-
tended dissemination of the CTX-M-15 ESBL, it seems most
likely that ST131 has specialized via horizontal gene transfer to
become a multidrug-resistant ExPEC and then recombined
less due to ecological or genetic factors. The emergence of
this strain as a highly successful and dominant lineage would
then most probably be as a result of selection through drug
resistance.
When one considers the reasons for sexual restriction of
admixture in E. coli ST131, then there are two main plausible
discussion points. The first would be mechanistic barriers to
cross BAPS cluster admixture via physical prevention or a grad-
ual increase in genetic incompatibility as there is a selective
advantage to reduce recombination and limit loss of advanta-
geous genes. The second would be ecological isolation by
reduced opportunity to meet and recombine with strains of
other BAPS clusters. Fully addressing this question requires
further focused research, particularly in furthering our inade-
quate understanding of the ecology of human pathogenic
E. coli and especially ExPEC. It has been reported that ST131
is found in companion animals (Ewers et al. 2010; Platell,
Johnson, et al. 2011; Platell et al. 2011) and in poultry food
products (Vincent et al. 2010); however, the actual route of
dissemination and transmission is still not known for certain
with some studies suggesting UTI caused by E. coli may some-
times be transmitted as a sexually transmitted infection
(Foxman 2010) as opposed to the classical fecal–urethral
route considered clinical dogma. A favoring for the role of
ecological separation leading to the detected recombination
pattern in E. coli may be taken when one considers the cluster
with the next lowest level of detectable core recombination to
ST131, that of BAPS cluster 9. This cluster contains E. coli
O157 strains and their ancestral O55 relatives. Escherichia
coli O157 is a pathogenic variant, which has become globally
successful. Moreover, E. coli O157 is ecologically distinct in
that it causes acute infections in humans leading to a transient
and brief colonization of the intestinal tract and is found to
only colonize the recto-anal junction of livestock as opposed
to the more microbially rich intestinal lumen (Naylor et al.
2003). This would suggest that the lineage has less opportu-
nity to recombine with distant E. coli lineages due to reduced
opportunity to interact in the mammalian intestinal tract.
Similarly, the recent observations on the phylogeography of
Shigella also fit with our postulated model of HGT-driven di-
vergence and then ecological separation-driven reduction in
recombination (Holt et al. 2012). Shigella are a subset of
E. coli, which have become niche restricted to the human
intestinal tract where they are highly pathogenic, and display
extreme monomorphism across a large population set, with
little to no recombination. Only by better understanding the
ecology of ST131 would we be able to draw fuller inferences
and comparisons.
In conclusion, we present novel data on the population
structure of E. coli. Recombination analysis on this scale has
not been previously undertaken for E. coli due to its com-
putational complexity, and advanced model-based tools are
the key to unraveling the mysteries of complex evolutionary
processes. Our data suggest that the emergence of new
pathogenic and drug-resistant lineages of E. coli are marked
by reduction in detectable recombination within the core
genome, which is typified by analysis of the E. coli ST131
clone. Our data raise new questions on the evolution
and emergence of new pathogenic E. coli variants and
opens up new avenues of research to further our under-
standing of the ecology and interactions of extraintestinal
pathogenic E. coli
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Supplementary Material
Supplementary figure S1, tables S1–S6, and file S7 are avail-
able at Genome Biology and Evolution online (http://www.
gbe.oxfordjournals.org).
Acknowledgments
The authors thank Prof Nicholas Thomson for helpful com-
ments on the manuscript. This work was supported by ERC
grant no. 239784, Academy of Finland grant no. 251170, and
a grant from Sigrid Juselius Foundation to J.C.; by population
genetics graduate school and a grant from Sigrid Juselius
Foundation to L.C.; and by grant no CRD-2-1 from EMDA
iNET sponsored by EU to A.M.
Literature Cited
Avasthi TS, et al. 2011. Genome of multidrug-resistant uropathogenic
Escherichia coli strain NA114 from India. J Bacteriol. 193:4272–4273.
Bono JL, et al. 2012. Phylogeny of shiga toxin-producing Escherichia coli
O157 isolated from cattle and clinically ill humans. Mol Biol Evol. 29:
2047–2062.
Clark G, et al. 2012. Genomic and molecular epidemiology analysis of
clinical Escherichia coli ST131 isolates suggests circulation of a genet-
ically monomorphic but phenotypically heterogeneous ExPEC clone.
J Antimicrob Chemother. 67:868–877.
Clermont O, Bonacorsi S, Bingen E. 2000. Rapid and simple determination
of the Escherichia coli phylogenetic group. Appl Environ Microbiol. 66:
4555–4558.
Corander J, Connor TR, O’Dwyer CA, Kroll JS, Hanage WP. 2012.
Population structure in the Neisseria, and the biological significance
of fuzzy species. J R Soc Interface. 9:1208–1215.
Corander J, Marttinen P. 2006. Bayesian identification of admixture events
using multi-locus molecular markers. Mol Ecol. 15:2833–2843.
Corander J, Marttinen P, Sire´n J, Tang J. 2008. Enhanced Bayesian model-
ling in BAPS software for learning genetic structures of populations.
BMC Bioinformatics 16:539.
Croxall G, et al. 2011. Molecular epidemiology of extraintestinal patho-
genic Escherichia coli isolates from a regional cohort of elderly patients
highlights the prevalence of ST131 strains with increased antimicrobial
resistance in both community and hospital care settings. J Antimicrob
Chemother. 66:2501–2508.
Croxen M, Finlay B. 2010. Molecular mechanisms of Escherichia coli path-
ogenicity. Nat Rev Microbiol. 8:26–38.
Didelot X, Meric G, Falush D, Darling AE. 2012. Impact of homologous and
non-homologous recombination in the genomic evolution of
Escherichia coli. BMC Genomics 13:256.
Dobrindt U, Hochhut B, Hentschel U, Hacker J. 2004. Genomic islands in
pathogenic and environmental microorganisms. Nat Rev Microbiol. 2:
414–424.
Dykhuizen DE, Green L. 1991. Recombination in Escherichia coli and the
definition of biological species. J Bacteriol. 173:7257–7268.
Ender PT, et al. 2009. Transmission of an extended-spectrum-beta-lacta-
mase-producing Escherichia coli (sequence type ST131) strain between
a father and daughter resulting in septic shock and emphysematous
pyelonephritis. J Clin Microbiol. 47:3780–3782.
Ewers C, et al. 2010. Emergence of human pandemic O25:H4-ST131 CTX-
M-15 extended-spectrum-beta-lactamase-producing Escherichia coli
among companion animals. J Antimicrob Chemother. 65:651–660.
Foxman B. 2010. The epidemiology of urinary tract infection. Nat Rev Urol.
7:653–660.
Hanage WP, Fraser C, Tang J, Connor T, Corander J. 2009. Hyper-recom-
bination, diversity and antibiotic resistance in the pneumococcus.
Science 324:1454–1457.
Holt KE, et al. 2012. Shigella sonnei genome sequencing and phylogenetic
analysis indicate recent global dissemination from Europe. Nat Genet.
44:1056–1059.
Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. 2010.
Escherichia coli type ST131 as the major cause of serious multidrug-
resistant Escherichia coli infections in the United States. Clin Infect Dis.
51:286–294.
Johnson JR, Porter SB, Zhanel G, Kuskowski MA, Denamur E. 2012.
Virulence of Escherichia coli clinical isolates in a murine sepsis model
in relation to sequence type ST131 status, fluoroquinolone resistance,
and virulence genotype. Infect Immun. 80:1554–1562.
Kaper JB, Nataro JP, Mobley HL. 2004. Pathogenic Escherichia coli. Nat Rev
Microbiol. 2:123–140.
Lau SH, et al. 2008. UK epidemic Escherichia coli strains A–E, with CTX-M-
15 b-lactamase, all belong to the international O25:H4-ST131 clone.
J Antimicrob Chemother. 62:1241–1244.
Leopold SR, et al. 2009. A precise reconstruction of the emergence
and constrained radiations of Escherichia coli O157 portrayed by
backbone concatenomic analysis. Proc Natl Acad Sci U S A. 106:
8713–8718.
Lloyd AL, Henderson TA, Vigil PD, Mobley HLT. 2009. Genomic islands of
uropathogenic Escherichia coli contribute to virulence. J Bacteriol. 191:
3469–3481.
Lloyd AL, Rasko DA, Mobley HLT. 2007. Defining genomic islands
and uropathogen-specific genes in uropathogenic Escherichia coli.
J Bacteriol. 189:3532–3546.
Lukjancenko O, Wassenaar TM, Ussery DW. 2010. Comparison of 61
sequenced Escherichia coli genomes. Microb Ecol. 60:708–720.
Marttinen P, et al. 2012. Detection of recombination events in
bacterial genomes from large population samples. Nucleic Acid Res.
40:e6.
Naylor SW, et al. 2003. Lymphoid follicle-dense mucosa at the terminal
rectum is the principal site of colonization of enterohemorrhagic
Escherichia coli O157:H7 in the bovine host. Infect Immun. 71:
1505–1512.
Nicolas-Chanoine M, et al. 2008. Intercontinental emergence of Escher-
ichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob
Chemother. 61:273–281.
Olesen B, et al. 2012. Enteroaggregative Escherichia coli O78:H10—the
cause of an outbreak of urinary tract infection. J Clin Microbiol. 50:
3703–3711.
Peirano G, Pitout JDD. 2010. Molecular epidemiology of Escherichia coli
producing CTX-M b-lactamases: the worldwide emergence of clone
ST131 O25:H4. Int J Antimicrob Agents. 35:316–321.
Pitout JDD, Campbell L, Church DL, Gregson DB, Laupland KB. 2009.
Molecular characteristics of travel-related extended-spectrum-b-lacta-
mase-producing Escherichia coli isolates from the Calgary health
region. Antimicrob Agents Chemother. 53:2539–2543.
Platell JL, et al. 2011. Commonality among fluoroquinolone-resistant se-
quence type ST131 extraintestinal Escherichia coli isolates from
humans and companion animals in Australia. Antimicrob Agents
Chemother. 8:3782–3787.
Platell JL, Johnson JR, Cobbold RN, Trott DJ. 2011. Multidrug-resistant
extraintestinal pathogenic Escherichia coli of sequence type ST131 in
animals and foods. Vet Microbiol. 153:99–108.
Price MN, Dehal PS, Arkin AP. 2009. FastTree: computing large minimum
evolution trees with profiles instead of a distance matrix. Mol Biol Evol.
26:1641–1650.
Rasko DA, et al. 2008. The pangenome structure of Escherichia coli: com-
parative genomic analysis of Escherichia coli commensal and patho-
genic isolates. J Bacteriol. 190:6881–6893.
Recombination in Drug Resistant ExPEC GBE
Genome Biol. Evol. 5(4):699–710. doi:10.1093/gbe/evt038 Advance Access publication March 14, 2013 709
 at N
ational Library of H
ealth Sciences on A
ugust 10, 2016
http://gbe.oxfordjournals.org/
D
ow
nloaded from
 
Rasko DA, et al. 2011. Origins of the Escherichia coli strain causing an
outbreak of hemolytic-uremic syndrome in Germany. New Engl J Med.
365:709–717.
Rogers BA, Sidjabat HE, Paterson DL. 2011. Escherichia coli O25b-ST131: a
pandemic, multiresistant, community-associated strain. J Antimicrob
Chemother. 66:1–14.
Rooney PJ, et al. 2009. Nursing homes as a reservoir of extended-spectrum
b-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli.
J Antimicrob Chemother. 64:635–641.
Sahl JW, et al. 2011. Genomic comparison of multi-drug resistant invasive
and colonizing Acinetobacter baumannii isolated from diverse human
body sites reveals genomic plasticity. BMC Genomics 12: 291.
Schloss PD, et al. 2009. Introducing mothur: open-source, platform-inde-
pendent, community-supported software for describing and compar-
ing microbial communities. Appl Environ Microbiol. 75:7537–7541.
Stamatakis A, Ludwig T, Meier H. 2005. RAxML-III: a fast program for
maximum likelihood-based inference of large phylogenetic trees.
Bioinformatics 21:456.
Tang J, Hanage WP, Fraser C, Corander J. 2009. Identifying currents in the
gene pool for bacterial populations using an integrative approach.
PLoS Comp Biol. 5:e1000455.
Toh H, et al. 2010. Complete genome sequence of the wild-type com-
mensal Escherichia coli Strain SE15, belonging to phylogenetic group
B2. J Bacteriol. 192:1165–1166.
Totsika M, et al. 2011. Insights into a multidrug-resistant Escherichia coli
pathogen of the globally disseminated ST131 lineage: genome analysis
and virulence mechanisms. PLoS One 6:e26578.
Touchon M, et al. 2009. Organised genome dynamics in the Escherichia
coli species results in highly diverse adaptive paths. PLoS Genet. 5:
e1000344.
Vincent C, et al. 2010. Food reservoir for Escherichia coli causing urinary
tract infections. Emerg Infect Dis. 16:88–95.
Willems RJ, et al. 2012. Restricted gene flow among hospital subpopula-
tions of Enterococcus faecium. MBio 3:e00151–12.
Wirth T, et al. 2006. Sex and virulence in Escherichia coli: an evolutionary
perspective. Mol Microbiol. 60:1136–1151.
Zong Z, Yu R. 2011. blaCTX-M-carrying Escherichia coli of the O25b ST131
clonal group have emerged in China. Diagn Microbiol Infect Dis. 69:
228–231.
Associate editor: Josefa Gonzalez
McNally et al. GBE
710 Genome Biol. Evol. 5(4):699–710. doi:10.1093/gbe/evt038 Advance Access publication March 14, 2013
 at N
ational Library of H
ealth Sciences on A
ugust 10, 2016
http://gbe.oxfordjournals.org/
D
ow
nloaded from
 
